Does Amiodarone Interfere with Thyroid Nuclear Scans?
Yes, amiodarone significantly interferes with thyroid nuclear scans, but the nature and degree of interference depends on the type of thyroid dysfunction present and the specific radioisotope used.
Mechanism of Interference
Amiodarone is an iodine-rich compound that releases large amounts of inorganic iodine, which directly impacts radioiodine uptake studies 1. The drug contains approximately 37% iodine by weight and causes sustained elevation of plasma iodide levels that can persist for weeks to months even after discontinuation due to its extremely long half-life (averaging 58 days) 2.
Impact on Different Scan Types
Radioiodine (I-123 or I-131) Uptake Studies
The interference pattern varies dramatically based on the underlying thyroid condition:
In amiodarone-induced hypothyroidism: Radioiodine uptake remains detectable and measurable, regardless of whether underlying thyroid disease is present 3. This occurs despite the massive iodine load from amiodarone.
In amiodarone-induced thyrotoxicosis (AIT): The uptake pattern differentiates the two main types 3:
- Type 1 AIT (iodine-induced hyperthyroidism with underlying thyroid disease): Normal or even elevated radioiodine uptake may be seen 3
- Type 2 AIT (destructive thyroiditis): Very low or absent radioiodine uptake 3
- However, radioiodine uptake was measurable in 4 out of 10 patients with Type 2 AIT in one study, demonstrating inconsistent suppression 4
Radioactive iodine therapy is contraindicated in amiodarone-induced hyperthyroidism due to the characteristically low radioiodine uptake 1
Alternative Nuclear Medicine Scans
Technetium-99m (Tc-99m) pertechnetate scans can be performed and may provide diagnostic information in AIT patients 5. Unlike radioiodine, technetium uptake is not as severely suppressed by the iodine load, though its clinical utility remains debated 5.
Tc-99m-sestaMIBI (MIBI) thyroid scintigraphy has emerged as a superior alternative that is not significantly affected by amiodarone's iodine content 4:
- Normal/increased uptake in all Type 1 AIT patients 4
- Absent uptake in all Type 2 AIT patients 4
- MIBI scintigraphy proved superior to color-flow Doppler sonography and radioiodine uptake for differentiating AIT types 4
Clinical Implications and Recommendations
For diagnostic workup of suspected thyroid dysfunction in amiodarone patients:
Avoid relying solely on radioiodine uptake studies as they provide inconsistent and potentially misleading results 4, 3
Consider Tc-99m-MIBI scintigraphy as the preferred nuclear imaging modality when differentiation between Type 1 and Type 2 AIT is needed, as it is not significantly impacted by amiodarone's iodine load and demonstrates superior diagnostic accuracy 4
Ultrasound with color-flow Doppler should be the first-line imaging study per ACR guidelines, as it evaluates thyroid morphology without interference from iodine 6
If technetium scanning is considered, it may be most cost-effective in patients with known thyroid nodules detected on physical examination or ultrasound, rather than as a routine screening tool 5
Important Caveats
The effects of amiodarone on thyroid function and imaging persist for weeks to months after drug discontinuation due to tissue storage and slow elimination 1, 7
Thyroid function monitoring should continue long-term even after amiodarone withdrawal, as late-onset thyroid dysfunction can occur 7
In pediatric patients, clinically significant thyroid changes may occur within 2 weeks of amiodarone initiation, requiring more frequent monitoring than standard adult protocols 8
The perchlorate discharge test shows consistent patterns (positive in hypothyroid patients, negative in hyperthyroid patients on amiodarone) and may provide additional diagnostic information 3